Correction to: Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis: A Profile of Its Use

被引：0
|
作者：
Yvette N. Lamb
机构：
[1] Springer Nature,
来源：
Clinical Drug Investigation | 2020年 / 40卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The original article has been corrected.
引用
收藏
页码：103 / 103
相关论文
共 50 条
  • [21] Topical Glycopyrronium Tosylate for the Treatment of Primary Axillary Hyperhidrosis: Patient-Reported Outcomes from the ATMOS-1 and ATMOS-2 Phase III Randomized Controlled Trials
    Pariser, David M.
    Hebert, Adelaide A.
    Drew, Janice
    Quiring, John
    Gopalan, Ramanan
    Glaser, Dee Anna
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2019, 20 (01) : 135 - 145
  • [22] Long-term efficacy of glycopyrronium cloth in patients with primary axillary hyperhidrosis
    Lain, E. L.
    Glaser, D. A.
    Gopalan, R.
    Yan, V.
    Drew, J.
    Pariser, D. M.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB234 - AB234
  • [23] Topical glycopyrronium tosylate (DRM04) for the treatment of primary axillary hyperhidrosis: Pooled results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials
    Pariser, David
    Hebert, Adelaide
    Nast, Alexander
    Werschler, William
    Shideler, Stephen
    Green, Lawrence
    Mamelok, Richard
    Quiring, John
    Drew, Janice
    Glaser, Anna
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB298 - AB298
  • [24] An evaluation of anticholinergic adverse events with long-term use of glycopyrronium cloth, a treatment for primary axillary hyperhidrosis
    Pariser, D. M.
    Drew, J.
    Gopalan, R.
    Hebert, A. A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB19 - AB19
  • [25] NEW TOPICAL PHOTODYNAMIC THERAPY FOR MANAGEMENT OF PRIMARY AXILLARY HYPERHIDROSIS
    Attia, Abeer
    Salah, Manal
    LASERS IN SURGERY AND MEDICINE, 2011, 43 : 958 - 958
  • [26] Efficacy and safety of topical glycopyrronium bromide in treating axillary hyperhidrosis: systematic review and meta-analysis
    Elrosasy, Amr
    Zeid, Mohamed Abo
    Samha, Raghad
    Alkousheh, Hazim
    Cadri, Shirin
    Cadri, Nina
    Mashaly, Doaa
    Ehab, Aya
    Abdullah, Lava
    Aledani, Esraa M.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [27] Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials
    Hebert, Adelaide A.
    Glaser, Dee Anna
    Green, Lawrence
    Werschler, William P.
    Forsha, Douglass W.
    Drew, Janice
    Gopalan, Ramanan
    Pariser, David M.
    PEDIATRIC DERMATOLOGY, 2019, 36 (01) : 89 - 99
  • [28] Long-term efficacy and safety of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Post hoc pediatric subgroup analysis from a 44-week open-label extension study
    Hebert, Adelaide A.
    Glaser, Dee Anna
    Green, Lawrence
    Hull, Cheryl
    Cather, Jennifer
    Drew, Janice
    Gopalan, Ramanan
    Pariser, David M.
    PEDIATRIC DERMATOLOGY, 2020, 37 (03) : 490 - 497
  • [29] A glycopyrronium bromide 1% cream for topical treatment of primary axillary hyperhidrosis: efficacy and safety results from a phase IIIa randomized controlled trial
    Abels, C.
    Soeberdt, M.
    Kilic, A.
    Reich, H.
    Knie, U.
    Jourdan, C.
    Schramm, K.
    Heimstaedt-Muskett, S.
    Masur, C.
    Szeimies, R. -M.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (02) : 315 - 322
  • [30] Glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Previous treatment analyses from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials
    Pariser, David
    Hebert, Adelaide
    Nast, Alexander
    Werschler, William
    Shideler, Stephen
    Green, Lawrence
    Mamelok, Richard
    Quiring, John
    Drew, Janice
    Glaser, Dee Anna
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB147 - AB147
12345